Process for reacting a carboxylic acid ester
The invention provides a process for reacting a carboxylic acid ester of the formula (I) R 1 -A-COOR 2 (I), wherein R 1 is hydrogen, —CH 2 OH, —CHO, —COOR 3 , —CH 2 SH, —CH 2 OR 3 or —CH 2 NH 2 , R 2 is an alkyl group, R 3 is hydrogen or an alkyl group, and A is a substituted, unsubstituted, linear, branched and/or cyclic alkylene, alkenylene, arylene or aralkylene radical having at least 4 carbons, in the presence of a cell. The process comprises a) contacting the cell with said carboxylic acid ester in an aqueous solution, wherein the cell is a recombinant cell which has reduced activity of a polypeptide comprising SEQ ID NO: 2 or a variant thereof over the wild-type cell.
1. A process for transforming a carboxylic acid ester of the formula (I) into a second carboxylic acid ester:
R 1 -A-COOR 2 (I),
where
R 1 is hydrogen, —CH 2 OH, —CHO, —COORS, —CH 2 SH, —CH 2 OR 3 or —CH 2 NH 2 ,
R 2 is an alkyl group,
R 3 is hydrogen or an alkyl group, and
A is an unsubstituted, a linear, or an unsubstituted and linear alkylene radical having at least 10 carbons,
the process comprising:
contacting a recombinant cell with the carboxylic acid ester of the formula (I) in an aqueous solution to convert the carboxylic acid ester of the formula (I) to the second carboxylic acid ester,
wherein the recombinant cell has a reduced activity of a polypeptide comprising SEQ ID NO: 2 or a polypeptide having at least 70% homology to SEQ ID NO:2 and having essentially the same enzymatic activity as the polypeptide comprising SEQ ID NO:2 compared to an activity in a corresponding wild-type cell due to knockout of a gene encoding the polypeptide comprising SEQ ID NO:2 or the polypeptide having at least 70% homology to SEQ ID NO:2 and having essentially the same enzymatic activity as the polypeptide comprising SEQ ID NO:2,
the recombinant cell comprises a polypeptide having at least 80% sequence identity to consecutive 230 amino acids of SEQ ID NO: 15 and having essentially the same enzymatic activity as Pseudomonas putida AlkL, where the polypeptide is optionally overexpressed,
the recombinant cell has been transformed to express a transaminase, Pseudomonas putida AlkBGT, and an alanine dehydrogenase,
the recombinant cell has a reduced activity of at least one enzyme catalyzing any of reactions of fatty acid β-oxidation compared to an activity in the wild-type cell due to knockout, and
the at least one enzyme catalyzing any of reactions of fatty acid β-oxidation is selected from the group consisting of fatty acid-CoA ligase, acyl-CoA dehydrogenase, 2,4-dienoyl-CoA reductase, enoyl-CoA hydratase, 3-ketoacyl-CoA thiolase, and a fatty acid importer.
2. The process according to claim 1 , further comprising:
contacting the aqueous solution with a hydrophobic organic solution comprising a cation exchanger.
3. The process of claim 1 , wherein
R 2 is methyl, ethyl or propyl,
R 3 is methyl, ethyl or propyl, and
A is an unsubstituted, a linear, or an unsubstituted and linear alkylene radical having 11 carbons.
4. The process according to claim 1 , wherein A is an unsubstituted and linear alkylene radical.
5. The process according to claim 1 , wherein R 1 is hydrogen, —CH 2 OH, —CHO or —CH 2 NH 2 .
6. The process according to claim 1 , wherein A is an alkylene radical of formula —(CH 2 ) n —, where n is at least 10.
7. The process according to claim 1 , wherein the second carboxylic acid ester has the formula (I′):
R 1 -A-COOR 2 (I′),
where
R 1 is hydrogen, —CH 2 OH, —CHO, —COORS, —CH 2 SH, —CH 2 OR 3 or —CH 2 NH 2 ,
R 2 is an alkyl group,
R 3 is hydrogen or an alkyl group, and
A is an unsubstituted, a linear, or an unsubstituted and linear alkylene radical having at least 10 carbons.
8. The process according to claim 1 , wherein the carboxylic acid ester of the formula (I) is methyl dodecanoate.
9. The process according to claim 1 , wherein the second carboxylic acid ester comprises methyl 12-amino-dodecanoate.
10. The process according to claim 1 , wherein the at least one enzyme catalyzing any of reactions of fatty acid β-oxidation comprises at least one of FadA, FadB, FadD, FadL, and FadE from Escherichia coli.
11. The process according to claim 1 ,
wherein R 1 is hydrogen, —CH 2 OH, —CHO or —CH 2 NH 2 ,
R 2 is methyl, ethyl or propyl, and
A is an alkylene radical of formula —(CH 2 ) n —, where n is at least 10.
12. The process according to claim 1 ,
wherein the cell has a reduced activity of a polypeptide comprising SEQ ID NO: 2 or a polypeptide having at least 90% homology to SEQ ID NO:2 and having essentially the same enzymatic activity as the polypeptide comprising SEQ ID NO:2 compared to an activity in a corresponding wild-type cell due to knockout of a gene encoding the polypeptide comprising SEQ ID NO:2 or the polypeptide having at least 90% homology to SEQ ID NO:2 and having essentially the same enzymatic activity as the polypeptide comprising SEQ ID NO:2, and
the recombinant cell comprises a polypeptide having at least 90% sequence identity to consecutive 230 amino acids of SEQ ID NO: 15 and having essentially the same enzymatic activity as Pseudomonas putida AlkL.
13. The process according to claim 1 ,
wherein the cell has a reduced activity of a polypeptide comprising SEQ ID NO: 2 or a polypeptide having at least 96% homology to SEQ ID NO:2 and having essentially the same enzymatic activity as the polypeptide comprising SEQ ID NO:2 compared to an activity in a corresponding wild-type cell due to knockout of a gene encoding the polypeptide comprising SEQ ID NO:2 or the polypeptide having at least 96% homology to SEQ ID NO:2 and having essentially the same enzymatic activity as the polypeptide comprising SEQ ID NO:2, and
the recombinant cell comprises a polypeptide having at least 90% sequence identity to consecutive 230 amino acids of SEQ ID NO: 15 and having essentially the same enzymatic activity as Pseudomonas putida AlkL.
14. The process according to claim 1 ,
wherein the carboxylic acid ester of the formula (I) is methyl dodecanoate, and
the second carboxylic acid ester comprises methyl 12-amino-dodecanoate.
15. The process according to claim 14 , wherein the recombinant cell is Escherichia coli , the transaminase is Chromobacterium violaceum Cv_2025, and the alanine dehydrogenase is Bacillus subtilis ald.
16. The process according to claim 15 , further comprising:
after the contacting, extracting the second carboxylic acid ester from the aqueous solution by contacting the aqueous solution with a hydrophobic organic solution comprising a cation exchanger.
17. The process according to claim 16 , wherein the recombinant cell comprises a polypeptide having the consecutive 230 amino acids of SEQ ID NO: 15.
18. A method for producing a carboxylic acid ester of the formula (I′) from a substrate carboxylic acid ester:
R 1 -A-COOR 2 (I′),
where
R 1 is hydrogen, —CH 2 OH, —CHO, —COORS, —CH 2 SH, —CH 2 OR 3 or —CH 2 NH 2 ,
R 2 is an alkyl group,
R 3 is hydrogen or an alkyl group, and
A is an unsubstituted, a linear, or an unsubstituted and linear alkylene radical having at least 10 carbons,
the method comprising:
contacting a recombinant cell with the substrate carboxylic acid ester in an aqueous solution to convert the substrate carboxylic acid ester to the carboxylic acid ester of the formula (I′),
wherein the recombinant cell comprises a knockout of a gene encoding a polypeptide comprising SEQ ID NO: 2 or a polypeptide having at least 70% homology to SEQ ID NO:2 and having essentially the same enzymatic activity as the polypeptide comprising SEQ ID NO:2,
the recombinant cell comprises a polypeptide having at least 80% sequence identity to consecutive 230 amino acids of SEQ ID NO: 15 and having essentially the same enzymatic activity as Pseudomonas putida AlkL, where the polypeptide is optionally overexpressed,
the recombinant cell has been transformed to express a transaminase, Pseudomonas putida AlkBGT, and an alanine dehydrogenase,
the production of the carboxylic acid ester of the formula (I′) is increased over a corresponding wild-type cell of the recombinant cell,
the recombinant cell has a reduced activity of at least one enzyme catalyzing any of reactions of fatty acid β-oxidation compared to an activity in the wild-type cell due to knockout, and
the at least one enzyme catalyzing any of reactions of fatty acid β-oxidation is selected from the group consisting of fatty acid-CoA ligase, acyl-CoA dehydrogenase, 2,4-dienoyl-CoA reductase, enoyl-CoA hydratase, 3-ketoacyl-CoA thiolase, and a fatty acid importer.
19. The method according to claim 18 ,
wherein the recombinant cell comprises a knockout of a gene encoding a polypeptide comprising SEQ ID NO: 2 or a polypeptide having at least 90% homology to SEQ ID NO:2 and having essentially the same enzymatic activity as the polypeptide comprising SEQ ID NO:2, and
the recombinant cell comprises a polypeptide having at least 90% sequence identity to consecutive 230 amino acids of SEQ ID NO: 15 and having essentially the same enzymatic activity as Pseudomonas putida AlkL.
20. The method according to claim 18 ,
wherein the recombinant cell comprises a knockout of a gene encoding a polypeptide comprising SEQ ID NO: 2 or a polypeptide having at least 96% homology to SEQ ID NO:2 and having essentially the same enzymatic activity as the polypeptide comprising SEQ ID NO:2, and
the recombinant cell comprises a polypeptide having at least 90% sequence identity to consecutive 230 amino acids of SEQ ID NO: 15 and having essentially the same enzymatic activity as Pseudomonas putida AlkL.